Results 11 to 20 of about 6,121 (198)

Testing of newly synthesized propafenone derivatives antiarrhythmic activity in aconitic model of cardiac arrhythmia in rats [PDF]

open access: yesVeterinarski Glasnik, 2014
By applying of aconitic test in in vivo experiments in rats under deep anesthesia, there was investigated the antiarrhythmic potential of newly synthetized fluorinated derivatives of propafenone.
Ivković Branka   +6 more
doaj   +2 more sources

Propafenone and propranolol dual toxicity

open access: yesJournal of the American College of Emergency Physicians Open, 2020
Propranolol is a highly lipid‐soluble beta‐receptor antagonist and propafenone is a potent class 1c anti‐arrhythmic agent with strong Na‐channel blockade effect.
Moonis Farooq   +3 more
doaj   +2 more sources

Experience with propafenone for the treatment of cardiac arrhythmias in children

open access: yesThe Turkish Journal of Pediatrics, 1990
The aim of this prospective study was to evaluate the efficacy of propafenone in suppressing various arrhythmias in a group of children who were patients in the Pediatric Cardiology Unit of Hacettepe University Children's Hospital. Seven of the 13
A Celiker   +4 more
doaj   +3 more sources

Propafenone-Induced Cholestatic Liver Injury: When Diagnosis Does Not Skip a Beat

open access: yesGE: Portuguese Journal of Gastroenterology
Introduction: Propafenone is a widely used class Ic antiarrhythmic drug that is mainly metabolised by the liver. Hepatotoxicity associated with propafenone is rare, with only a few clinical cases reported in the literature.
Ana Isabel Ferreira   +5 more
doaj   +2 more sources

Propafenone and amiodarone efficacy in paroxysmal atrial fibrillation treatment

open access: yesРоссийский кардиологический журнал, 2006
To assess antiarrhythmic efficacy of propafenone and amiodarone in paroxysmal atrial fibrillation (AF) treatment, 204 patients (125 males, 79 females, aged 57-72 years) with various stages of heart failure (HF) were examined.
N. N. Isakova   +5 more
doaj   +1 more source

Suicide attempt of young woman by Propafenone overdose - case report [PDF]

open access: yesJournal of Education, Health and Sport, 2023
Introduction and purpose: Over the last few years, the number of suicide attempts in Polish women has been steadily increasing. This report presents a case of a 18 years old woman hospitalized in the Toxicology and Cardiology Department due to poisoning
Marcin Wais   +2 more
doaj   +2 more sources

Chronic Propafenone Application Increases Functional KIR2.1 Expression In Vitro

open access: yesPharmaceuticals, 2023
Expression and activity of inwardly rectifying potassium (KIR) channels within the heart are strictly regulated. KIR channels have an important role in shaping cardiac action potentials, having a limited conductance at depolarized potentials but ...
Encan Li   +3 more
doaj   +2 more sources

Propafenone efficacy in paroxysmal atrial fibrillation

open access: yesРоссийский кардиологический журнал, 2004
Efficacy and safety of class IС antiarrhythmic agent, propafenone, was investigated in patients with paroxysmal atrial fibrillation (PAF), after single-dose load and during long-term preventive treatment.
V. V. Skibitsky   +4 more
doaj   +1 more source

POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY [PDF]

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To identify possible predictors of atrial fibrillation (AF) recurrence in 6-month prophylactic propafenone therapy. Material and methods. Patients (n=63; aged 52.2±12.6 years; 25.4% women) with frequent AF recurrences who restored sinus rhythm with ...
R. D. Kurbanov   +3 more
doaj   +4 more sources

Risk of Severe Hypoglycemia Associated With Concomitant Use of Sulfonylureas and Amiodarone. [PDF]

open access: yesDiabetes Obes Metab
ABSTRACT Aims To evaluate whether initiation of amiodarone while receiving sulfonylurea is associated with an increased risk of severe hypoglycemia compared with the initiation of other antiarrhythmic agents (flecainide, sotalol, or propafenone) while receiving sulfonylurea. Materials and Methods We conducted a population‐based cohort study using South
Bea S   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy